510(k) Report

PMA · Approved

Approved

Visian ICL (Implantable Collamer Lens), Visian Toric ICL (Implantable Collamer Lens), Visian EVO/EVO+ ICL (Implantable C

P030016/S046PMAApproved May 10, 20249-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

STAAR Surgical Company · MTA Lens, Intraocular, Phakic

Approved on May 10, 2024 through premarket approval, which rests on the device’s own clinical evidence after a 9-day review.

Decided
May 10, 2024
Review
9 days
Class
Class III
Product code
MTA
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P030016/S046Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MTA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MTA devices

MTA Lens, Intraocular, Phakic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · MTA

2in 2025

2008: 72009: 32010: 52011: 42012: 22013: 12014: 22015: 22017: 52018: 32019: 62020: 12021: 12022: 42024: 42025: 22026 (partial year): 2
2007high 7 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MTA

Too few MTA 510(k)s in any year since 2007 to give a median.

Recalls per year · MTA

7in 2023

2023: 72026 (partial year): 1
2007high 7 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MTA

655in 2025

2007: 42008: 2262009: 6012010: 5512011: 3112012: 5002013: 6962014: 7812015: 1,2792016: 1,4562017: 1,7962018: 1,7782019: 1,2362020: 1,4402021: 2,0632022: 1,9172023: 2,0762024: 2,1482025: 655
2007high 2,148 (2024) · low 4 (2007)2025

MAUDE reports naming product code MTA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—04
20087—0226
20093—0601
20105—0551
20114—0311
20122—0500
20131—0696
20142—0781
20152—01,279
20160—01,456
20175—01,796
20183—01,778
20196—01,236
20201—01,440
20211—02,063
20224—01,917
20230—72,076
20244—02,148
20252—0655
20262—1—
Cite this page

510(k) Report. “P030016/S046: Visian ICL (Implantable Collamer Lens), Visian Toric ICL (Implantable Collamer Lens), Visian EVO/EVO+ ICL (Implantable C.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P030016/S046

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026